Generics Fight Nifedipine Direct Purchaser Class

Law360 (October 23, 2007, 12:00 AM EDT) -- Biovail Corp., Elan Corp. plc and Teva Pharmaceuticals Ltd. have opposed certification of a direct purchaser class in the multidistrict litigation a slew of distributors and stores filed against them for allegedly divvying up the market for a generic hypertension drug to keep prices high.

The companies filed papers with the U.S. District Court for the District of Columbia on Monday, rejecting the plaintiffs' claim that the companies' challenges to the certification of a nationwide class of direct purchasers suing under the Sherman Act didn't make...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.